Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
John W Hollis Inc is recalling 7 vials of Phosphatidylcholine Solution for Injection because the expiration date on the label is earlier than the date listed on the vial.
AbbVie is recalling 7,362 Lupron Depot kits because some may contain a syringe with a defective needle stick protection device.
Caraco Pharmaceutical Laboratories is recalling 91,777 bottles of Venlafaxine Hydrochloride Extended-Release Tablets, 37.5 mg, because stability results showed the product did not meet drug release dissolution specifications.
Teva Pharmaceuticals is recalling Fluoxetine Capsules due to a customer complaint trend regarding capsule odor, indicating chemical contamination.
Legacy Pharmaceutical Packaging is recalling 667,068 bottles of Fluoxetine Capsules, 20 mg, due to supplier complaints of unusual odor.
P&L Developments is recalling 1,363,338 bottles of Children's Triacting Night Time Cold & Cough with PE because small amounts of diphenhydramine and mannitol precipitated out of solution.
AbbVie is recalling 1,530 Lupron Depot kits because some may contain a syringe with a defective needle stick protection device.
John W Hollis Inc is recalling specific vials of Papaverine, Phentolamine, and Atropine solution due to an incorrect expiration date on the label.
Aaron Industries is recalling 108,792 bottles of Tussin DM cough syrup because a white substance, identified as the active ingredient Guaifenesin, was observed in some bottles.
Apotex Inc. is recalling Risperidone Oral Solution because it failed impurity specifications at the 18-month stability time point.
Genesis Pharmaceuticals is recalling 461 bottles of Glytone Acne Treatment Facial Cleanser due to out-of-specification viscosity results.
John W Hollis Inc is recalling 2 vials of Polidocanol 1% Solution because the expiration date on the vial is earlier than the date listed on the label.
Caraco Pharmaceutical Laboratories is recalling specific lots of Cetirizine Hydrochloride Chewable Tablets because they failed impurity testing.
Shire Human Genetic Therapies is recalling 8,359 vials of VPRIV (velaglucerase alfa) because they contain stainless steel and barium sulfate particles.
Dolphin Intertrade Corporation is recalling XIYOUJI QINGZHI CAPSULES because they contain undeclared sibutramine, a substance removed from the U.S. market for safety reasons.
Fossil Fuel Products, LLC is recalling RezzRX capsules because they contain undeclared hydroxylthiohomosildenafil and aminotadalafil.
Dolphin Intertrade Corporation is recalling JaDera weight loss capsules because they contain undeclared sibutramine, a drug removed from the U.S. market for safety reasons.
Brookfield Prescription Center Inc. is recalling one lot of Glycopyrrolate solution for injection due to Bacillus thuringiensis contamination.
Hospira is recalling 255,900 vials of Potassium Chloride for Injection due to the presence of red and black particulate matter identified as iron oxide.
GlaxoSmithKline is recalling Nicorette 2 mg lozenges because they failed specifications for thickness, softness, and potency.
Pfizer is recalling Tikosyn (dofetilide) 500 mcg capsules because a single 250 mcg capsule was found in one bottle. The recall covers 23,064 bottles distributed nationwide.
P&L Developments, LLC is recalling 2,500,510 bottles of Day Time Cold & Flu because the phenylephrine component is subpotent.
GlaxoSmithKline is recalling Nicorette 4 mg lozenges because they failed specifications for thickness, softness, and potency.
GlaxoSmithKline is recalling specific lots of Nicorette 4 mg lozenges because they failed quality specifications, including being overly thick, soft, and sub or superpotent.
GlaxoSmithKline is recalling specific lots of Nicorette 2 mg lozenges because they failed quality specifications, including being overly thick, soft, and sub or superpotent.